We’re exploring new research linking GLP-1 medications, like Ozempic and Wegovy, not just to weight loss and diabetes management, but to a potential reduction in cancer risk. An eight-year study has found that these drugs may lower the risk of several obesity-related cancers. A leading expert in integrative health and wellness Dr. Pete Sulack joins the show to unpack the findings!